Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions

Poster Presentation to Include 24-Month Follow-Up Results from Original 10 kHz Arm of SENZA-PDN Randomized Controlled Trial SENZA-PDN Study Results Selected to be Featured in ADA's Official Press Program Company to Participate in ADA's Product Theater Presentation REDWOOD CITY, Calif.,...

Click to view original post